Carbetocin

Generic Name
Carbetocin
Brand Names
Duratocin
Drug Type
Small Molecule
Chemical Formula
C45H69N11O12S
CAS Number
37025-55-1
Unique Ingredient Identifier
88TWF8015Y
Background

Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.

Indication

Used to control postpartum hemorrhage and bleeding after giving birth.

Associated Conditions
Postpartum Haemorrhage (PPH), Uterine Atony
Associated Therapies
-
Clinical Trials
Related News

Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage

First Posted Date
2020-03-09
Last Posted Date
2020-03-09
Lead Sponsor
National and Kapodistrian University of Athens
Target Recruit Count
100
Registration Number
NCT04300452
Locations
🇬🇷

Hospital "Elena Venizelou", Athens, Attiki, Greece

EMG for Uterotonic Efficiency Estimation

Not Applicable
Completed
Conditions
Postpartum Hemorrhage
Interventions
Drug: Carbetocin
Drug: Oxytocin
First Posted Date
2019-12-17
Last Posted Date
2022-06-27
Lead Sponsor
University Medical Centre Ljubljana
Target Recruit Count
60
Registration Number
NCT04201665
Locations
🇸🇮

UMC Ljubljana, Ljubljana, Slovenia

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.

Not Applicable
Completed
Conditions
Postpartum Hemorrhage
Twin
Interventions
Drug: Carbetocin
First Posted Date
2019-12-02
Last Posted Date
2023-07-06
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
30
Registration Number
NCT04182360
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH

First Posted Date
2019-09-13
Last Posted Date
2019-09-13
Lead Sponsor
Rajavithi Hospital
Target Recruit Count
120
Registration Number
NCT04089176
Locations
🇹🇭

Rajavithi Hospital, Bangkok, Thailand

Database Evaluating Outcomes of Using Carbetocin as the Primary Uterotonic Following Cesarean Delivery

First Posted Date
2019-05-22
Last Posted Date
2019-05-29
Lead Sponsor
Maisonneuve-Rosemont Hospital
Target Recruit Count
612
Registration Number
NCT03959436
Locations
🇨🇦

Maisonneuve-Rosemont hospital, Montreal, Quebec, Canada

Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections

First Posted Date
2019-05-07
Last Posted Date
2019-05-13
Lead Sponsor
Ufuk University
Target Recruit Count
100
Registration Number
NCT03939806
Locations
🇹🇷

Ufuk University Faculty of Medicine Hospital, Ankara, Balgat, Turkey

Carbetocin Myocardium Trial 2014 Part 2

Phase 4
Completed
Conditions
Pregnancy Complications
Interventions
Drug: Oxytocin
Drug: Carbetocin
First Posted Date
2019-04-02
Last Posted Date
2022-05-26
Lead Sponsor
Oslo University Hospital
Target Recruit Count
240
Registration Number
NCT03899961
Locations
🇳🇴

Akershus University Hospital, Lørenskog, Norway

🇳🇴

Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway

Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage

Not Applicable
Completed
Conditions
Post Partum Hemorrhage
Interventions
Drug: Carbetocin
Drug: misoprostol
Drug: TA
First Posted Date
2019-03-12
Last Posted Date
2021-09-29
Lead Sponsor
Aswan University Hospital
Target Recruit Count
135
Registration Number
NCT03870256
Locations
🇪🇬

AswanUH, Aswan, Egypt

Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage

First Posted Date
2019-03-12
Last Posted Date
2021-09-29
Lead Sponsor
Aswan University Hospital
Target Recruit Count
135
Registration Number
NCT03870503
Locations
🇪🇬

Aswan University Hospital, Aswan, Egypt

Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section

First Posted Date
2018-12-17
Last Posted Date
2019-02-15
Lead Sponsor
Aswan University Hospital
Target Recruit Count
400
Registration Number
NCT03777878
Locations
🇪🇬

Aswan University, Aswan, Egypt

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy